論文 2023年

2023年

英文

  1. Yamairi K, Niki M, Imoto W, Kuwabara G, Shibata W, Oshima K, Yamada K, Kaneko Y, Kakeya H. Two cases of Clostridium ramosum bacteremia with intestinal perforation: the antimicrobial susceptibility of clinical strains. Anaerobe, 2023 Jan12;80:102695. doi: 10.1016/j.anaerobe.2023.102695.
  2. Kobayashi M, Miyamoto A, Watanabe T, Sawa K, Sato K, Yamada K, Yoshii N, Yamada K, Kawamoto K, Uji M, Shiraishi S, Asai K, Kakeya H, Kawaguchi T. COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan. Respir Investig. 2023;61(2):230-239. doi: 10.1016/j.resinv.2022.12.011.
  3. Ogawa M, Niki M, Imoto W, Dobashi A, Imai M, Takayama N, Mitani K, Kakuno S, Shibata W, Yamada K, Kakeya H. Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019. J Infect Chemother. 2023;29(6):580-585. doi: 10.1016/j.jiac.2023.02.001.COVID-19
  4. Nakaya Y, Nakashima Y, Harada N, Yamada K, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Nanno S, Nishimoto M, Koh H, Nakagama Y, Kido Y, Kanno T, Suzuki T, Nakamae H, Kakeya H, Hino M. Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2023;29:223-227. doi: 10.1016/j.jiac.2022.10.020.
  5. Thoda M, Oinuma KI, Sakiyama A, Tsubouchi T, Niki M, Namikawa H, Yamane K, Yamada K, Watanabe T, Asai K, Kakeya H, Kaneko Y, Kawaguchi T. Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via the binding to RNA polymerase β subunit. J Glob Antimicrob Resist. 2023;32:21-28. doi: 10.1016/j.jgar.2022.11.018.
  6. Namikawa H, Oinuma KI, Yamada K, Kaneko Y, Kakeya H, Shuto T. Predictors of hypervirulent Klebsiella pneumoniae infections: a systematic review and meta-analysis. J Hosp Infect. 2023;134:153-160. doi: 10.1016/j.jhin.2023.02.005.
  7. Namikawa H, Oinuma KI, Yamada K, Kaneko Y, Kakeya H, Shuto T. Differences in severity of bacteraemia caused by hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae. Int J Antimicrob Agents. 2023;61(5):106767. doi: 10.1016/j.ijantimicag.
  8. Kakuno S, Imoto W, Teranishi Y, Kakeya H. Lomentospora prolificans-induced Invasive Fungal Sinusitis. Intern Med. 2023;62(18):2761-2762. doi: 10.2169/internalmedicine.
  9. Namikawa H, Imoto W, Yamada K, Tochino Y, Kaneko Y, Kakeya H, Shuto T. Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis. J Hosp Infect. 2023;142:88-95. doi: 10.1016/j.jhin.2023.09.017.
  10. Kawaguchi H, Kakeya H, Nakagami-Yamaguchi E. Assessing the Impact of COVID-19 on Incident Reporting and Elucidating the Characteristics of Incident Reports for COVID-19 Patients at the Critical Care Center of a Tertiary-Care TeachingHospitalinJapan.TohokuJExpMed.2023Oct19.doi:10.1620/tjem.2023.J087.
  11. Takagi I, Harada N, Niki M, Yamada K, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Nishimoto M, Nakashima Y, Koh H, Kakeya H, Hino M, Nakamae H. Fulminant Metastatic Cellulitis Caused by Stenotrophomonas Maltophilia Infection and Subsequent Candida Parapsilosis Fungemia After Cord Blood Transplantation.TransplantProc.2023;55(3):706-710.doi:10.1016/j.transproceed.2023.02.028.
  12. Ogura Y, Yaguchi T, Kasamatsu Y, Nakagawa Y, Yamada T, Maruyama A, Miyagawa-Hayashino A, Takayama K, Shibuya K, Kakeya H, Kam disseminated blastomycosis imported from North America ei K. First Japanese case of: A case report. J Infect Chemother. 2023;29(10):988-992. doi: 10.1016/j.jiac.2023.06.004.
  13. Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y, Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S. A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19. Microbiol Spectr. 2023;11(3):e0431122. doi: 10.1128/spectrum.04311-22.
  14. Deguchi R, Nishimura T, Matsuo K, Wakita F, Kawamoto A, Uchida K, Yamamoto H, Yamada K, Kakeya H, Fujii H, Shibata T, Mizobata Y. Factors associated with the outcome of patients with COVID-19 requiring mechanical ventilation: A single-center observational study in Japan. Acute Med Surg. 2023;10(1):e868. doi: 10.1002/ams2.868.
  15. Yamada K, Imoto W, Shibata W, Kakuno S, Nakaie K, Myodo Y, Takayama N, Dobashi A, Imai M, Mitani K, Ogawa M, Niki M, Sakurai N, Nonose Y, Okada Y, Fujita A, Kaneko Y, Kakeya H. Impact of antimicrobial stewardship with the Xpert MRSA/SA BC assay at a tertiary hospital in Japan. J Infect Chemother. 2023;29(7):693-699. doi: 10.1016/j.jiac.2023.03.021.
  16. Namikawa H, Tochino Y, Okada A, Ota K, Okada Y, Yamada K, Watanabe T, Mizobata Y, Kakeya H, Kuwatsuru Y, Shibata T, Shuto T. Mental health complaints among healthcare workers engaged in the care of COVID-19 patients: A prospective cohort study from Japan. J Gen Fam Med. 2023;24(4):240-246. doi: 10.1002/jgf2.632.
  17. Makuuchi Y, Tanaka S, Koh H, Niki M, Norose K, Nakaya Y, Ido K, Sakatoku K, Kuno M, Harada N, Takakuwa T, Hirose A, Okamura H, Nishimoto M, Nakashima Y, Nakamae M, Hikosaka K, Kakeya H, Ohsawa M, Hino M, Nakamae H. Sinusoidal obstruction syndrome associated with disseminated toxoplasmosis involving the liver after allogeneic hematopoietic stem cell transplantation: A case report. J Infect Chemother. 2023;29(9):909-912. doi: 10.1016/j.jiac.2023.05.009.
  18. Tashiro M, Namie H, Ito Y, Takazono T, Kakeya H, Miyazaki Y, Mukae H, Mikamo H, Tomoo F, Shibuya K, Izumikawa K. Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan. Open Forum Infect Dis. 2023;10(10):ofad480. doi: 10.1093/ofid/ofad480.
  19. Tokimatsu I, Matsumoto T, Tsukada H, Fujikura Y, Miki M, Morinaga Y, Sato J, Wakamura T, Kiyota H, Tateda K, Yanagisawa H, Sasaki T, Ikeda H, Horikawa H, Takahashi H, Seki M, Mori Y, Takeda H, Kurai D, Hasegawa N, Uwamino Y, Kudo M, Yamamoto M, Nagano Y, Nomura S, Tetsuka T, Hosokai M, Aoki N, Yamamoto Y, Iinuma Y, Mikamo H, Suematsu H, Maruyama T, Kawabata A, Sugaki Y, Nakamura A, Fujikawa Y, Fukumori T,Ukimura A, Kakeya H, Niki M, Yoshida K, Kobashi Y, Tokuyasu H, Yatera K, Ikegami H, Fujita M, Matsumoto T, Yanagihara K, Matsuda J, Hiramatsu K, Shinzato T. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, theJapanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility.JInfectChemother.2023;29(8):731-743.doi:10.1016/j.jiac.2023.04.008.
  20. Barit JJ, Hiroyasu S, Yamada K, Tsuruta D. Malignant syphilis in a young immunocompetent patient presenting as ulceronecrotic lesions on the lower extremities. Int J Dermatol. 2023;62:1070-1072. doi: 10.1111/ijd.16640.
  21. Shiomi I, Makuuchi Y, Noura I, Kakuno S, Niki M, Kaimi Y, Ido K, Sakatoku K, Kuno M, Takakuwa T, Okamura H, NishiInvasivemoto M, NakashimaY, Nakamae M, Kakeya H, Kohashi K, Hino M, Nakamae H. fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report. J Infect Chemother. doi.org/10.1016/j.jiac.2023.12.002

和文

  1. 掛屋　弘, 河野　茂. 感染症の臨床症状と診断. 井村裕夫編　第５版　わかりやすい内科学. 文光堂, 東京, 2023. pp 367-372
  2. 掛屋　弘. ウイルス性出血熱. 今日の治療指針2023. 医学書院 2023, pp170-172.
  3. 仁木　誠, 井本和紀, 山田康一, 金子幸弘, 掛屋　弘. 血液培養から検出されたClostridium属およびClostridioides属の細菌学的検討. 日本嫌気性菌学会雑誌 2023;52(2):66-77.
  4. 井本和紀, 掛屋弘. 医療・介護関連肺炎（NHCAP）. 弦間昭彦監修　呼吸器内科学レビュー2024-‘25. 総合医学社, 東京, 2023. pp 55-58.
  5. 井本和紀, 掛屋弘. 肺炎・結核. 糖尿病ケア+ 2023;19:835-837.
  6. 覺野 重毅, 掛屋 弘. 真菌感染症の予防と治療. 血液内科, 87巻1号, 112－119, 2023.
  7. 柴多　渉. 掛屋　弘. 深在性真菌症の薬物治療 ムーコル症. 薬事 65(8);1599-1602, 2023
  8. 掛屋　弘. 特集「真菌感染症の診断と治療の進歩」総論 新型コロナウイルス感染症と真菌感染症の診療と研究の進歩. BIO Clinica 38(6);466-467, 2023
  9. 掛屋　弘、岡田恵代. 全国地域連携の取り組み紹介 大阪市感染対策支援ネットワーク（Osaka City Infection Control and Prevention Network） INFECTION CONTROL　2023年夏季増刊 192-196, 2023
  10. 掛屋　弘. 特集市中感染症の診断と治療　皮膚・軟部組織感染症. 日内学誌 112(11);2068-2075, 2023
  11. 掛屋　弘, 櫻井紀宏. MRSA肺炎. 呼吸器疾患最新の治療2023-2024, 南江堂, 2023, pp 250-252.
  12. 仁木　誠, 掛屋　弘. 総説　Antifungal stewardshipに貢献する微生物検査と当院の真菌症診療支援への取り組み. 真菌誌 64; 59-66, 2023
  13. 掛屋　弘. 特集　希少真菌症の診断・治療ガイドラインから学ぶ　希少深在性真菌症の診断・治療ガイドラインの概要. 真菌誌 64;73-76, 2023
  14. 掛屋　弘, JAID／JSC感染症治療ガイド2023, 呼吸器感染症（委員長）
  15. 木村俊一、柴多　渉, 沖中敬二, 阿部雅広, 荒岡秀樹, 三村健介, 戸所大輔, 掛屋　弘. 特集　希少真菌症の診断・治療ガイドラインから学ぶ　日本医真菌学会希少深在性真菌症の診断・治療ガイドライン, システマティックレビューワーキンググループの取り組み. 真菌誌 64;87-95, 2023
  16. 山田康一, 山岸由佳（委員長）. JAID/JSC感染症治療ガイド2023 Ⅲ　細菌性髄膜炎　編集：JAID/JSC 感染症治療ガイド・ガイドライン作成委員会
  17. 山田康一, 掛屋　弘(委員長). JAID/JSC感染症治療ガイド2023 Ⅶ 呼吸器感染症 　編集：JAID/JSC 感染症治療ガイド・ガイドライン作成委員会
  18. 井本和紀, 掛屋 弘. 医療・介護関連肺炎（NHCAP）. 呼吸器内科学レビュー. 総合医学社, 東京. 2023. pp55-58.
論文 2024年
論文バックナンバーに戻る
論文 2022年